Exploring the Validity of Valproic Acid Animal Model of Autism
The valproic acid (VPA) animal model of autism spectrum disorder (ASD) is one of the most widely used animal model in the field. Like any other disease models, it can't model the totality of the features seen in autism. Then, is it valid to model autism? This model demonstrates many of the stru...
Saved in:
Published in | Experimental neurobiology Vol. 24; no. 4; pp. 285 - 300 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society for Brain and Neural Science
01.12.2015
한국뇌신경과학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The valproic acid (VPA) animal model of autism spectrum disorder (ASD) is one of the most widely used animal model in the field. Like any other disease models, it can't model the totality of the features seen in autism. Then, is it valid to model autism? This model demonstrates many of the structural and behavioral features that can be observed in individuals with autism. These similarities enable the model to define relevant pathways of developmental dysregulation resulting from environmental manipulation. The uncovering of these complex pathways resulted to the growing pool of potential therapeutic candidates addressing the core symptoms of ASD. Here, we summarize the validity points of VPA that may or may not qualify it as a valid animal model of ASD. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 G704-SER000009883.2015.24.4.006 |
ISSN: | 1226-2560 2093-8144 |
DOI: | 10.5607/en.2015.24.4.285 |